Liver cancer is the third leading cause of cancer-related deaths worldwide. To date, treatment options for two liver cancers, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while new cases are on the rise. Hope has now been raised by a study conducted by researchers at the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI).